Abstract
Increased ileal permeability may play a role in the pathogenesis of Crohn's disease (CD). fMLP, a common bacterial peptide, initiates inflammation and increased permeability in the rat ileum via neutrophil activation and chemotaxis. We investigated the effect of 6MP often used to treat CD, upon fMLP-induced changes in ileal macromolecular uptake. METHODS: Using in situ ileal perfusion, permeability to 0.5%. horseradish peroxidase (HRP), ± simultaneous luminal perfusion of 10 −5M fMLP, was measured by blood levels over 90 min, in each of 3 groups of male rats: Group I = daily 48 mg 6MP m−2 for 14 days; Group II = vehicle-injected, pair fed controls; Group III = ad libitum controls. RESULTS: In the absence of fMLP, HRP uptake was low in all Groups (90 min blood HRP <37 ± 5 units)(mean ± SE). With fMLP, HRP uptake was markedly elevated over basal in rats not receiving CMP: Group II = 210 ± 12; Group III = 263 ± 24 units, (p<0.01). Conversely, 6MP treatment (Group I) ameliorated the fMLP response (106 ± 8 units, p<0.01). 6MP therapy decreased the circulating neutrophil count, but did not alter mucosal myeloperoxidase, a neutrophil marker.
CONCLUSION: 6MP therapy decreases macromolecular uptake induced by fMLP. SPECULATION: In CD, CMP may be therapeutic through diminished neutrophil inflammatory response and reduced antigen uptake.
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Khoshoo, V., Daum, F., Karl, P. et al. 6 MERCAPTOPURINE (6MP) REDUCES FORMYL-METHIONYL-LEUCYL-PHENYLALANINE (fMLP) INDUCED MACROMOLECULAR UPTAKE IN RAT ILEUM. Pediatr Res 27, 543 (1990). https://doi.org/10.1203/00006450-199005000-00109
Issue date:
DOI: https://doi.org/10.1203/00006450-199005000-00109
